US Stock MarketDetailed Quotes
WVE Wave Life Sciences
- 14.270
- -0.080-0.56%
Close Nov 22 16:00 ET
- 14.270
- 0.0000.00%
Post 20:01 ET
2.18BMarket Cap-12741P/E (TTM)
14.520High14.084Low455.93KVolume14.510Open14.350Pre Close6.50MTurnover0.67%Turnover RatioLossP/E (Static)152.52MShares16.73552wk High15.36P/B966.11MFloat Cap3.50052wk Low--Dividend TTM67.70MShs Float56.000Historical High--Div YieldTTM3.04%Amplitude1.160Historical Low14.263Avg Price1Lot Size
Wave Life Sciences Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -34.89%-46.48M | 26.27%-27.47M | -139.09%-33.43M | 84.79%-19.43M | 0.60%-33.24M | -34.36%-34.46M | -29.27%-37.26M | 314.49%85.52M | -43.59%-127.78M | -375.47%-33.44M |
| Net income from continuing operations | -951.90%-61.78M | -56.00%-32.92M | -15.15%-31.56M | 64.46%-57.51M | 62.81%-16.26M | 118.59%7.25M | 48.90%-21.1M | 27.53%-27.41M | -32.38%-161.82M | -25.65%-43.71M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --12K | ---- |
| Depreciation and amortization | -4.68%2.16M | -6.46%2.17M | -10.71%2.18M | -8.98%9.21M | -12.55%2.18M | -12.96%2.26M | -7.27%2.32M | -3.02%2.44M | 2.84%10.11M | -1.69%2.5M |
| Change In working capital | 120.78%9.61M | 99.03%-202K | -106.43%-6.93M | 183.86%19.08M | -543.19%-21.52M | -725.86%-46.26M | -791.52%-20.88M | 1,360.99%107.74M | -4.11%6.72M | -77.41%4.86M |
| -Change in receivables | 118.43%1.29M | ---1.29M | --21.09M | ---21.09M | ---14.09M | ---7M | --0 | --0 | --0 | --0 |
| -Change in prepaid assets | 5.14%1.58M | -560.27%-1.01M | 5.54%-1.23M | -46.88%-1.98M | -367.45%-2.4M | 174.05%1.5M | -85.82%219K | -264.89%-1.3M | -135.01%-1.35M | -149.19%-513K |
| -Change in payables and accrued expense | -159.79%-1.61M | 235.97%10.16M | 22.80%-11.28M | -137.25%-4.49M | -41.44%4.4M | -46.51%2.7M | -38.64%3.03M | -168.36%-14.6M | 427.41%12.04M | 129.92%7.51M |
| -Change in other current assets | 778.31%2.39M | 98.95%-6K | 22.73%-1.39M | -159.22%-2.01M | 183.49%91K | -95.01%272K | 48.04%-569K | -111.99%-1.8M | 1,104.14%3.39M | 92.13%-109K |
| -Change in other current liabilities | -1.31%-1.71M | -14.26%-1.66M | -58.08%-1.58M | -38.08%-5.69M | -95.83%-1.55M | -81.36%-1.68M | 30.46%-1.45M | -222.19%-1M | 5.57%-4.12M | 63.55%-791K |
| -Change in other working capital | 118.26%7.68M | 71.04%-6.4M | -109.92%-12.54M | 1,774.21%54.33M | -543.34%-7.97M | -27,742.38%-42.04M | -8,057.56%-22.11M | 8,082.83%126.45M | 82.43%-3.25M | 29.80%-1.24M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -34.89%-46.48M | 26.27%-27.47M | -139.09%-33.43M | 84.79%-19.43M | 0.60%-33.24M | -34.36%-34.46M | -29.27%-37.26M | 314.49%85.52M | -43.59%-127.78M | -375.47%-33.44M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -93.43%-383K | 27.78%-52K | 14.72%-417K | 11.16%-1.12M | -101.43%-356K | 60.48%-198K | -100.29%-72K | 99.03%-489K | -124.11%-1.26M | 165,700.00%24.84M |
| Net PPE purchase and sale | -93.43%-383K | 27.78%-52K | 14.72%-417K | 11.16%-1.12M | -74.51%-356K | 56.67%-198K | 81.35%-72K | -135.10%-489K | -124.11%-1.26M | -1,260.00%-204K |
| Net investment purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | --25.04M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -93.43%-383K | 27.78%-52K | 14.72%-417K | 11.16%-1.12M | -101.43%-356K | 60.48%-198K | -100.29%-72K | 99.03%-489K | -124.11%-1.26M | 165,700.00%24.84M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 12,100.36%203.75M | -64.68%653K | -58.61%14.51M | 97.26%132.53M | 170,740.00%93.96M | 9,723.53%1.67M | -97.19%1.85M | 2,563.60%35.05M | 20.35%67.19M | -99.84%55K |
| Net common stock issuance | 14,234.80%188.65M | -68.99%547K | -59.45%14.04M | 150.89%131.28M | 121,624.68%93.57M | 888.02%1.32M | -96.57%1.76M | 3,033.30%34.62M | -4.81%52.33M | -100.23%-77K |
| Proceeds from stock option exercised by employees | 4,165.54%15.1M | 24.71%106K | 9.77%472K | -91.54%1.26M | 193.94%388K | 92.39%354K | -99.41%85K | 103.79%430K | 1,632.28%14.86M | --132K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 12,100.36%203.75M | -64.68%653K | -58.61%14.51M | 97.26%132.53M | 170,740.00%93.96M | 9,723.53%1.67M | -97.19%1.85M | 2,563.60%35.05M | 20.35%67.19M | -99.84%55K |
| Net cash flow | ||||||||||
| Beginning cash position | -10.73%157.69M | -13.00%184.64M | 121.42%204.05M | -40.24%92.16M | 42.76%143.63M | 39.29%176.64M | 224.68%212.22M | -40.24%92.16M | -18.04%154.22M | -21.12%100.61M |
| Current changes in cash | 575.63%156.89M | 24.28%-26.87M | -116.10%-19.34M | 281.07%111.99M | 806.46%60.37M | -26.23%-32.99M | -157.60%-35.48M | 235.29%120.09M | -83.39%-61.85M | -131.95%-8.55M |
| Effect of exchange rate changes | 475.00%120K | 19.00%-81K | -252.38%-74K | 54.76%-95K | -38.30%58K | 57.89%-32K | 29.58%-100K | 75.58%-21K | -0.96%-210K | 222.08%94K |
| End cash Position | 119.11%314.69M | -10.73%157.69M | -13.00%184.64M | 121.42%204.05M | 121.42%204.05M | 42.76%143.63M | 39.29%176.64M | 224.68%212.22M | -40.24%92.16M | -40.24%92.16M |
| Free cash flow | -35.22%-46.86M | 26.28%-27.52M | -139.81%-33.85M | 84.09%-20.55M | 0.15%-33.6M | -32.76%-34.66M | -27.34%-37.33M | 312.15%85.03M | -44.21%-129.14M | -377.36%-33.64M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data